Financial Health Assessment — ATTRAQT LIMITED (04631635)

Important Caveat Before We Begin

A financial health check is only as good as the vitals you can take. For this company, the dataset supplied contains no financial statements — no profit and loss account, no balance sheet, no cash figures, no revenue. What we have is the corporate record: registration details, filing compliance, ownership, directors and business description.

So this is a triage assessment, not a full diagnosis. I can assess the corporate "skeleton and nervous system" with confidence. I cannot yet assess the "blood pressure and blood chemistry" — the money. I've graded accordingly and flagged exactly which readings are needed to complete the picture.

1. Financial Health Score

B– (Provisional)

Why not higher: A financial health grade fundamentally rests on profitability, liquidity and solvency. None of those can be verified here. Grading higher would be guessing.

Why not lower: There are no distress signals anywhere in the registry record. The company is active, filings are up to date, there is no liquidation, administration or receivership, and there are no director conduct or disqualification records in the data. A company in genuine trouble usually leaves fingerprints on the public record — overdue accounts, a change of registered office to an accountant's address, a flurry of director resignations, insolvency practitioner appointments. None of that is present.

What would move the grade: Filed accounts showing positive net assets, positive EBITDA and adequate working capital would push this to an A/B. Negative shareholders' funds, a going concern emphasis, or a reliance on parent support letters would pull it to C or below.

2. Key Vital Signs

The missing vitals — and why each one matters

• P&L reserve (accumulated profits/losses): the single most telling line for a subsidiary. A deeply negative reserve means losses have been absorbed by the parent.
• Net current assets (working capital): can the company pay its next twelve months of bills from its next twelve months of assets?
• Debtors and debtor days: in B2B software, receivables are where cash goes to hide. Rising debtor days is "inflammation" — a sign of collection problems or revenue being recognised ahead of cash.
• Cash at bank: the pulse you can actually feel.
• Intra-group creditors/debtors: for a subsidiary, this is often the largest balance sheet item and determines whether the company is really standalone-fundable.
• Going concern statement and audit status: does the parent provide a letter of support? Is the company audit-exempt?

3. Symptoms Analysis — What the Data Hints At

Symptom 1: Nominal capital + wholly-owned structure = dependency, not independence. With £1,630 of share capital, this company's equity base is essentially retained earnings plus parent funding. That is entirely normal for a group subsidiary — but it means the company's financial health is not self-determined. If the parent group sneezes, this entity catches the cold. Any assessment of this company must therefore be read alongside the group's accounts.

Symptom 2: Full accounts filing suggests substance. Choosing (or being required) to file full rather than abridged accounts points to a trading entity of real size, not a dormant holding vehicle. The website claim of 300+ brand customers is consistent with that.

Symptom 3: The filing deadline anomaly — worth a second look. The accounts period ends 31 January 2026, yet the next accounts are shown as due 31 October 2027 — roughly 21 months rather than the standard 9. That is unusual. It could reflect an accounting reference date change, a long accounting period, or a data artefact. It is not a red flag by itself, but it is the kind of detail a careful reader verifies rather than assumes.

Symptom 4: Board change in February 2026. One director resigned. In isolation, this is administrative. In combination with a group ownership structure, it more often signals group-level reorganisation than distress. Worth asking about, not worrying about.

Symptom 5: The sector's structural risk. Subscription software businesses can look healthy on the income statement while bleeding cash — growth funded by long sales cycles and slow collections. The classic pathology here is "growing while haemorrhaging": revenue up, cash down, debtors up faster than both.

Symptom 6: The SIC code is a catch-all. 63990 tells you almost nothing. It reduces comparability with peers and may under-describe the actual activity. Not a health issue — an information quality issue.

4. Diagnosis

Overall condition: structurally sound, financially unverified.

Think of this company as a specialist organ inside a larger body. On its own, its compliance reflexes are good, it has survived 23 years, and it shows no signs of acute distress. But its circulation runs through a parent company, and we have not been given the blood test results.

The honest clinical position is:

• Corporate health: good. Active, compliant, long-established, substantively trading.
• Financial health: indeterminate. No revenue, profit, cash, working capital or solvency data available.
• Structural risk: moderate and inherent. Wholly-owned subsidiary status means creditworthiness and continuity depend heavily on the parent's position.

5. Prognosis

Short term (next 12 months): stable. No overdue filings, no insolvency events, no adverse director records. The probability of an acute corporate event appearing on the public record in the near term is low based on what is visible.

Medium term: contingent on the parent. The single biggest determinant of this company's future is the financial condition of Attraqt Group Limited / Attraqt Group Plc. If the group is well capitalised, this entity is fine. If the group is itself under pressure, this entity will feel it first — through reduced intra-group funding, cost-cutting, or restructuring.

Sector outlook: mixed but reasonable. AI-driven search and merchandising is a competitive, fast-moving category with real demand but heavy R&D requirements. Recurring revenue contracts are a positive prognostic sign if they exist at scale.

6. Recommendations

If you are a creditor, supplier, landlord or counterparty: 1. Obtain the filed accounts for the year ended 31 January 2026 from Companies House — they were not included in this dataset and are the missing half of the diagnosis. 2. Read the parent's accounts too. For a >75%-owned subsidiary, group accounts are the more meaningful document. 3. Check the going concern note and any parent letter of support. This tells you whether the directors believe the company can fund itself. 4. Check the charges register for debentures or fixed charges — secured lending ahead of you changes your risk position materially. 5. Ask for management accounts if the exposure is significant. A 12-month rolling cash flow forecast answers in ten minutes what a year-old balance sheet cannot.

If you are a director, shareholder or adviser to the business: 1. Run the four core ratios quarterly: gross margin, EBITDA margin, debtor days, and cash conversion (operating cash flow ÷ EBITDA). These four catch most early-stage distress. 2. Watch the intra-group balance. If the company is a net debtor to its parent, confirm the repayment terms are genuinely flexible, not merely informal. 3. Monitor customer concentration. With a 300-brand customer base, check what percentage of revenue the top five represent. Above 30% is a concentration symptom worth treating. 4. Set calendar alerts for the accounts and confirmation statement deadlines. Compliance is currently healthy — protect that. 5. Clarify the accounting reference date position flagged above, so the next filing deadline is unambiguous. 6. Tidy the PSC register — the data shows duplicate entries for Attraqt Group Plc. Minor, but registers should be clean.

Universal recommendation: treat the absence of financial data as the finding itself. A company that cannot readily produce its numbers for scrutiny is, in a small way, exhibiting a symptom.